Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

17230-88-5 - Danazol - 17beta-Hydroxy-2,4,17a-pregnadien-20-yno[2,3-d]isoxazole - 2,4,17a-Pregnadien-20-yno[2,3-d]isoxazol-17-ol - J62200 - Alfa Aesar

J62200 Danazol

Codice CAS
17230-88-5
Sinonimi
17beta-Hydroxy-2,4,17a-pregnadien-20-yno[2,3-d]isoxazole
2,4,17a-Pregnadien-20-yno[2,3-d]isoxazol-17-ol

Dimensioni Prezzo ($) Quantità Disponibilità
100mg 50,16
500mg 217,33
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

Danazol

MDL
MFCD00056838
EINECS
241-270-1

Proprietà chimiche

Formula
C22H27NO2
Peso formula
337.46
Modulo
Powder
Punto di fusione
218-220°
Solubilità
Partly soluble in water. Soluble in chloroform (25 mg/ml), acetone, acetonitrile, and ethanol. 17beta-Hydroxy-2,4,17a-pregnadien-20-yno[2,3-d]isoxazole and 2,4,17a-Pregnadien-20-yno[2,3-d]isoxazol-17-ol are the synonym of this compound.

Applicazioni

Danazol is a synthetic gonadotropin inhibitor which has a preventive effect on estrogen -related endometrial carcinogenesis in mice. Danazol therapy has also shown regression of established mammary carcinoma in rats. This medication is used in women to treat pelvic pain and infertility due to a certain uterus disorder (endometriosis) and also to treat breast pain/tenderness/nodules due to a certain breast condition (fibrocystic breast disease). It is also used in both men and women to prevent swelling of the abdomen/arms/legs/face/airway due to a certain congenital disease

Note

Store at room temperature. Incompatible with oxidizing agents.

Letteratura

Gary G. Liversidge.; Kenneth C. Cundy. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs.Int. J. Pharm. 1995, 125 (1),91-97 .

Rischio GHS e dichiarazioni precauzionali

Dichiarazioni di rischio (UE): H361-H312-H332

Suspected of damaging fertility or the unborn child. Harmful in contact with skin. Harmful if inhaled.

Dichiarazioni precauzionali: P201-P261-P280-P281-P304+P340-P312-P363-P308+P313-P405-P501a

Obtain special instructions before use. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. Use personal protective equipment as required. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/physician if you feel unwell. Wash contaminated clothing before reuse. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Altri riferimenti

Merck
14,2812
Codice tariffe armonizzato
2937.29
TSCA
No
RTECS
TU4157070

Raccomandato

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio